论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
甲状腺状态与肺栓塞范围:肺栓塞患者中两者是否存在关联?
Authors Peng YF, Luo M, Luo HJ, Ma LY
Received 26 December 2024
Accepted for publication 20 May 2025
Published 10 June 2025 Volume 2025:18 Pages 2989—2993
DOI https://doi.org/10.2147/IJGM.S514365
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Vinay Kumar
You-Fan Peng,1,2 Miao Luo,2 Huai-Jun Luo,3 Li-Ya Ma1
1Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People’s Republic of China; 2Life Science and Clinical Medicine Research Center, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People’s Republic of China; 3Department of Radiology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, People’s Republic of China
Correspondence: You-Fan Peng, Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, No. 18 Zhongshan 2nd Road, Baise, Guangxi, 533000, People’s Republic of China, Email youfanpeng@hotmail.com
Background: Thyroid dysfunction has been associated with thrombotic diseases. However, the association between thyroid status and pulmonary thromboembolic extent remains unclear in patients with pulmonary embolism (PE). Thus, this study investigated the association between thyroid status and pulmonary thromboembolic extent and elucidated the clinical significance of thyroid status assessment in patients with PE.
Methods: We retrospectively analyzed data from 118 patients with PE. Pulmonary thromboembolic extent was assessed with computerized tomography obstruction index.
Results: Serum free triiodothyronine (FT3) levels were significantly higher in PE patients with greater pulmonary thromboembolic extent than in those with lesser pulmonary thromboembolic extent (4.33[4.04– 4.98] vs 4.17[3.33– 4.66] pmol/L, p=0.017), but not for serum free thyroxine (FT4) levels (15.33[13.43-16.94] vs 15.36[13.75-17.82] pmol/L, p=0.908) and serum thyroid stimulating hormone (TSH) levels (1.84[1.01-3.00] vs 1.49[0.74-2.58] uIU/mL, p=0.273). Multivariable linear regression analysis revealed that higher serum FT3 levels were independently associated with greater pulmonary thromboembolic extent in patients with PE (β=0.235, p=0.013).
Conclusion: Higher serum FT3 levels were associated with greater pulmonary thromboembolic extent in patients with PE. This finding suggests that the possibility of extensive pulmonary thromboembolic extent should be noticed for PE patients with higher serum FT3 levels.
Keywords: pulmonary embolism, pulmonary thromboembolic extent, thyroid status